| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-07 |
| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-06 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-06 |
| mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-06 |